Nasdaq biol.
Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors
Zomedica (NYSEMKT:ZOM), Tonix Pharmaceuticals (NASDAQ:TNXP), and Biolase (NASDAQ:BIOL) all were on a roller-coaster ride over the past few days. Except for online chatter, these penny stocks in ...Mar 30, 2023 · BIOL. BIOLASE, Inc. 1.2400. +0.0200. +1.64%. BIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Call Transcript March 28, 2023 Operator: Greetings. Welcome to the BIOLASE 2022 Fourth Quarter and Full ... Jan 25, 2023 · FOOTHILL RANCH, Calif., Jan. 25, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by ... NEW YORK, NY / ACCESSWIRE / March 25, 2021 / BIOLASE, Inc. (NASDAQ:BIOL) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 25, 2021 at 4:30 ...
LAKE FOREST, Calif., May 11, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the first quarter ended March 31, 2023 ...Nasdaq provides NLS Volume, Previous Close, Today's High & Low, and the 52 week High & Low. The intraday chart, the last-five real-time quotes and sales data. Real-time stock quotes can be used...These institutions hold a total of 1 shares. Largest shareholders include Huntington National Bank . Biolase Inc (NASDAQ:BIOL) institutional ownership structure ...
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate in the Benchmark Company...FOOTHILL RANCH, Calif., April 20, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products, announced in association with the American Association of Endodontists (AAE) Annual Meeting beginning on April 21, 2021, the co …
Nov 24, 2021 · At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news ... BIOLASE Inc (NASDAQ: BIOL) has announced to sell 14 million common shares at $1.03 per share, raising $14.4 million in gross proceeds. The offering price represents a discount of 15% from the last ...BIOL U.S.: Nasdaq. Biolase Inc. Watchlist. Alert. NEW. Set a price target alert ... Real-time last sale data for U.S. stock quotes reflect trades reported through ...Biolase: Q1 Earnings Snapshot. (AP Finance) +26.33%. 04:21PM. BIOLASE MAINTAINS MOMENTUM AND REPORTS NINTH CONSECUTIVE QUARTER OF YEAR-OVER …
LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten ...
BIOL Biolase Inc Statement of Ownership (sc 13g) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction ...
Biolase Inc (NASDAQ:BIOL) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for BIOL is 19.8. Stocks with higher ...Home BIOL • NASDAQ BIOLASE Inc Follow Share $1.15 Dec 1, 8:30:00 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to T2 Biosystems Inc $3.90 TTOO10.17% Assertio Holdings Inc $1.14... 8 Nov 2023 ... Biolase (NASDAQ:BIOL) shares are rising more than 24% with the release of positive study results. Upwork (NASDAQ:UPWK) stock is heading over .../PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it received notification from the Listing Qualifications...FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering ...Nasdaq +78.81(+0.55%) Russell 2000 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) BIOLASE, Inc. (BIOL) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W...
FOOTHILL RANCH, Calif., April 20, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products ...Dec 1, 2023 · The firm earned $10.92 million during the quarter. BIOLASE has generated ($158.82) earnings per share over the last year ( ($158.82) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates. BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its ...May-24-23 09:14AM. BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants. (PR Newswire) -39.91%. May-11-23 04:36PM. Biolase: Q1 Earnings Snapshot.Biolase Inc NASDAQ 1.090 -0.020 -1.80% After Hours: 1.130 +0.04 +3.67% 19:32 11/30 EST OPEN 1.140 PREV CLOSE 1.110 HIGH 1.180 LOW 1.071 VOLUME 237.58K …FOOTHILL RANCH, Calif., Nov. 4, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the two leading independent proxy advisory firms ...Leading Independent Proxy Advisory Firm ISS Recommends Sesen Bio Stockholders Vote “FOR” All Proposals at March 2 Special Meeting. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today announced that Institutional Shareholder Services (“ISS”) recommends that …
Nov 15, 2020 · Investors in BIOLASE, Inc. (NASDAQ:BIOL) had a good week, as its shares rose 7.1% to close at US$0.29 following the release of its third-quarter results. It was a pretty bad result overall; while ...
BIOLASE, Inc. (NASDAQ:BIOL) posted its quarterly earnings data on Wednesday, November, 10th. The medical technology company reported ($50.00) earnings per share for the quarter, topping analysts' consensus estimates of ($75.00) by $25.00. The medical technology company had revenue of $9.53 million for the quarter. NEW YORK, NY / ACCESSWIRE / March 25, 2021 / BIOLASE, Inc. (NASDAQ:BIOL) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 25, 2021 at 4:30 ...Biolase Inc NASDAQ 1.090 -0.020 -1.80% After Hours: 1.130 +0.04 +3.67% 19:32 11/30 EST OPEN 1.140 PREV CLOSE 1.110 HIGH 1.180 LOW 1.071 VOLUME 237.58K …BIOLASE Inc stock price (BIOL). NASDAQ: BIOL. Buying or selling a stock that's not traded in your local currency? Don't let the currency conversion trip you ...NEW YORK, NY / ACCESSWIRE / March 25, 2021 / BIOLASE, Inc. (NASDAQ:BIOL) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 25, 2021 at 4:30 ...Maybe you’ve never invested before. Maybe you have no clue what the difference is between NASDAQ and the New York Stock Exchange. Regardless, the name Charles Schwab probably rings a bell.Maybe you’ve never invested before. Maybe you have no clue what the difference is between NASDAQ and the New York Stock Exchange. Regardless, the name Charles Schwab probably rings a bell.BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, …Biolase: Q1 Earnings Snapshot. (AP Finance) +26.33%. 04:21PM. BIOLASE MAINTAINS MOMENTUM AND REPORTS NINTH CONSECUTIVE QUARTER OF YEAR-OVER …
LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public offering price of $0.35 per share or $0.34 per pre ...
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2022 honor by the Inland News Group. This award is in addition ...
Biolase, Inc. (Nasdaq: BIOL) is a global leader in dental lasers. In August 2022 , Biolase reported second quarter 2022 financial results, including total revenue of $12.2 million , a 34% year ...Biolase Inc (NASDAQ:BIOL) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for BIOL is 19.8. Stocks with higher ...Feb 10, 2022 · The image below, which you can click on for greater detail, shows that BIOLASE had debt of US$13.5m at the end of September 2021, a reduction from US$16.1m over a year. But it also has US$33.4m in ... BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, …Nov 15, 2020 · Investors in BIOLASE, Inc. (NASDAQ:BIOL) had a good week, as its shares rose 7.1% to close at US$0.29 following the release of its third-quarter results. It was a pretty bad result overall; while ... What is BIOLASE's consensus rating and price target? According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $77.00 with a high price target of $150.00 and a low price target of $4.00.BIOLASE (NASDAQ:BIOL) plummets 47.31% premarket on pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 ...FOOTHILL RANCH, Calif., Aug. 31, 2021 /PRNewswire/ -- Today BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced a clinical advisory partnership with Dr. L. Stephen Buchanan ...LAKE FOREST, Calif., May 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously ...P/E & PEG Ratios. Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the ... Overview Stock Screener Earnings Calendar Sectors Nasdaq | BIOL U.S.: Nasdaq Biolase Inc. Watch list Set a price target alert After Hours Last Updated: Nov 24, 2023 4:47 p.m. …
BIOLASE, Inc. (BIOL). NASDAQ: BIOL · IEX Real-Time Price · USD.Nov 8, 2023 · BIOL) stock’s latest price update. The stock price of Biolase Inc (NASDAQ: BIOL) has jumped by 6.01 compared to previous close of 1.58. Despite this, the company has seen a fall of -0.30% in its stock price over the last five trading days. FOOTHILL RANCH, Calif., Feb. 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, encourages stockholders to vote their shares with respect to the adjourned ...Instagram:https://instagram. health insurance carriers in marylandcall fubotvtruist chip loanquote xle LAKE FOREST, Calif., June 14, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that President and Chief Executive Officer, John Beaver and ... metachartbest brokerage accounts for options BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that based on currently available information, preliminary 2022 fourth quarter revenue is expected to be between ...Analyst Recommendations on BIOLASE, Inc. Biolase Files Registration Statement for Unit Offering at Target Price of $60 a Unit. Sep. 12. MT. Lake Street Adjusts Price Target on … jmst etf May 12, 2023 · Biolase (NASDAQ: BIOL) stock is taking a beating on Friday following the release of its earnings report for the first quarter of 2023. The bad news for investors in BIOL stock is the company’s ... BIOL’s shares have dropped by -21.84% in the last five days, while they have subtracted -8.67% in the last month. Further, it is currently trading at a price-to-book ratio of 1.12. LORD JONATHAN T MD, Director, of BIOLASE Inc. (BIOL), sold 11,038 BIOLASE Inc. stock in an exchange on Dec 15.BIOLASE, Inc.(NASDAQ: BIOL), the global leader in dental lasers, today announced groundbreaking findings from a 12-month follow-up to a clinical trial performed at The McGuire Institute™. The findings will be published in the November 2023 issue of the Journal of Periodontology. The pioneering study was designed to meet the stringent …